Home › Ovarian Cancer › California
Ovarian Cancer clinical trials in California
109 studies for Ovarian Cancer are looking for participants at sites in California.
Cities in California
- Los Angeles53 studies
- Baldwin Park27 studies
- San Diego24 studies
- San Francisco20 studies
- Mountain View19 studies
- Orange16 studies
- Irvine14 studies
- Santa Monica14 studies
- Newport Beach8 studies
- Sacramento7 studies
- Santa Rosa7 studies
- Concord5 studies
- Fullerton5 studies
- Huntington Beach4 studies
- Pleasanton4 studies
- Fresno4 studies
- Vallejo4 studies
- Burbank4 studies
- Santa Barbara4 studies
- San Jose4 studies
- Oakland3 studies
- Elk Grove3 studies
- Santa Clara3 studies
- Roseville3 studies
- Redwood City3 studies
- Arden-Arcade3 studies
- Richmond3 studies
- Fremont3 studies
- Antioch3 studies
- Modesto3 studies
- Long Beach3 studies
- Torrance3 studies
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine
- Cedars-Sinai Medical Center, Los Angeles
- UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange
- and 1 more
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07001748A Study to Evaluate OPB-201 in Recurrent Endometrial and Platinum-resistant Ovarian Cancer.
- UCSF - Helen Diller Family Comprehensive Cancer Center, San Francisco
RecruitingPhase 1
Ages 18 and older · Women · Updated Nov 12, 2026 · NCT07664735A Phase I/II, First-in-Human Study to Evaluate TJ102 in Participants With Advanced or Metastatic Ovarian Cancer and Other Solid Tumors.
- South Texas Accelerated Research Therapeutics START LLC, Los Angeles
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07778498Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- PCR Oncology, Arroyo Grande
- Mercy Cancer Center - Carmichael, Carmichael
- Mercy San Juan Medical Center, Carmichael
- and 15 more
RecruitingPhase 2
All ages · All sexes · Updated Nov 12, 2026 · NCT05564377A Clinical Trial of Raludotatug Deruxtecan (R-DXd) With or Without Bevacizumab in Participants With Ovarian Cancer Who Have Progressed During Treatment With PARP-inhibitors Treatment on First Line Maintenance (MK-5909-008/ENGOT-ov107/GOG-3142 / REJOICE-Ovarian05)
- MemorialCare Orange Coast Medical Center ( Site 0032), Fountain Valley
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 10, 2026 · NCT07743164A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)
- City of Hope Comprehensive Cancer Center ( Site 0007), Duarte
- City of Hope Lennar Foundation Cancer Center ( Site 0024), Irvine
- UCSF Medical Center at Mission Bay ( Site 0013), San Francisco
- and 1 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 10, 2026 · NCT06824467A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- UCSD Moores Cancer Center ( Site 0038), La Jolla
- John Muir Health Cancer Center ( Site 0069), Walnut Creek
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 10, 2026 · NCT07318558Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
- Kaiser Permanente-Deer Valley Medical Center, Antioch
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- Sutter Auburn Faith Hospital, Auburn
- and 87 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314A Study of Azenosertib (ZN-c3) Versus Investigator's Choice Chemotherapy in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancers Positive for Cyclin E1 Protein Expression
- Site 0110, Antioch
- Site 0104, Beverly Hills
- Site 0122, Fountain Valley
- and 2 more
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 9, 2026 · NCT07546500Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
- UC San Diego Health, La Jolla
- Cedars Sinai Medical Center, Los Angeles
RecruitingPhase 2
Ages 18 and older · Women · Updated Nov 6, 2026 · NCT06787612A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- Kaiser Permanente-Deer Valley Medical Center, Antioch
- Tower Cancer Research Foundation, Beverly Hills
- Keck Medicine of USC Buena Park, Buena Park
- and 57 more
Recruiting
Ages 35 to 50 · Women · Updated Nov 6, 2026 · NCT04251052The Vanguard Study: Testing a New Way to Screen for Cancer
- Kaiser Permanente-Division of Research, Pleasanton
- Naval Medical Center -San Diego, San Diego
RecruitingHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated Nov 6, 2026 · NCT06995898A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- University of California - Los Angeles, Los Angeles
RecruitingPhase 1
Ages 19 and older · All sexes · Updated Nov 5, 2026 · NCT06586957INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study
- University of California Los Angeles (UCLA), Los Angeles
RecruitingMentions payment for participants
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07671937A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
- City of Hope National Medical Center, Duarte
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
- UCLA Department of Medicine-Hematology/Oncology, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06465069A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center, Burbank
- City of Hope, Duarte, Duarte
- City of Hope Lennar, Irvine
- and 6 more
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07213804cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
- City of Hope, Duarte
RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older · All sexes · Updated Nov 4, 2026 · NCT05366881Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- University of California Los Angeles Medical Center, Los Angeles
- University of California, San Diego; Moores Cancer Center, San Diego
- USOR Sansum Clinic, Santa Barbara
- and 1 more
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT05579366A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06400472A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Hoag Memorial Hospital Presbyterian, Newport Beach
- Stanford University Medical Center, Stanford
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07213791Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- and 10 more
Recruiting
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT07059884A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- City of Hope - Duarte Cancer Center, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 4, 2026 · NCT06760819Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
- City of Hope, Duarte
RecruitingPhase 3
Ages 18 and older · Women · Updated Nov 4, 2026 · NCT07564141Study of RGT-490 in Patients With PIK3CA-Mutated Advanced Solid Tumors
- START Los Angeles, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 2, 2026 · NCT07524322DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
- USA06-0, Los Angeles
- USA16-0, Los Angeles
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 29, 2026 · NCT06953089A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- City of Hope, Duarte
- City of Hope, Irvine, Irvine
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT07109726Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
- Disney Family Cancer Center, Burbank
- Scripps Clinic, La Jolla
- Palo Alto Medical Foundation, Palo Alto
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 28, 2026 · NCT06819007Lead-212 PSV359 Therapy for Patients With Solid Tumors
- VA Greater Los Angeles Healthcare System, Los Angeles
- UCLA Department of Medicine - Hematology/Oncology, Los Angeles
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated Oct 28, 2026 · NCT06710756A Study of MGC026 in Participants With Advanced Solid Tumors
- The Angeles Clinic and Research Institute, Los Angeles
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 28, 2026 · NCT06242470A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Los Angeles Cancer Network, Los Angeles
- Pih Health Hematology Medical Oncology, Whittier
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06330064Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- University of California San Diego, La Jolla
- Stanford University, Palo Alto
- UCLA Medical Center, Santa Monica
RecruitingObservational study
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT04981119A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 26, 2026 · NCT06172478A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
- USC Norris Comprehensive Cancer Center, Los Angeles
- Providence Medical Foundation, Santa Rosa
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Oct 22, 2026 · NCT04657068AOH1996 for the Treatment of Refractory Solid Tumors
- City of Hope Medical Center, Duarte
- City of Hope at Long Beach Elm, Long Beach
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT05227326A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
- Kaiser Permanente - Irvine /ID# 276924, Irvine
- UCLA - University of California Los Angeles Medical Center /ID# 274566, Los Angeles
- Scripps Md Anderson - Prebys Cancer Center /ID# 276891, San Diego
- and 1 more
RecruitingPhase 2
Ages 18 and older · Women · Updated Oct 20, 2026 · NCT06890338Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
- and 2 more
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 20, 2026 · NCT06582017A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer
- City of Hope at Arcadia, Arcadia
- City of Hope Medical Center, Duarte
- City of Hope at Seacliff, Huntington Beach
- and 8 more
Recruiting
Ages 18 and older · Women · Updated Oct 16, 2026 · NCT07741968Study to Evaluate INCB123667 Versus Investigator's Choice of Chemotherapy in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
- City of Hope Medical Center, Duarte
- Valkyrie Clinical Trials, Los Angeles
RecruitingPhase 3
Ages 18 and older · Women · Updated Oct 15, 2026 · NCT07214779A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Other Anticancer Drugs in Adult Participants With Ovarian Cancer
- City of Hope National Medical Center /ID# 281381, Duarte
- City of Hope - Orange County Lennar Foundation Cancer Center /ID# 280914, Irvine
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Oct 13, 2026 · NCT07278336A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
- UC San Diego Health - Moores Cancer Center /ID# 277574, La Jolla
RecruitingPhase 2
Ages 18 and older · Women · Updated Oct 13, 2026 · NCT07059845From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.